Senticare, Inc. Receives FDA Approval For New Pillstation Telehealth System

Senticare, Inc. Receives Fda Approval For New Pillstation Telehealth System Developed To Combat Congestive Heart Failure (Chf) & Other Chronic Disease Related Hospital Readmissions

Company’s New PillStation Medication Adherence System to Be Launched At Annual HIMSS Conference in Orlando From February 20 – 24

Southborough, MA, February 15, 2011 – SentiCare, Inc. today announced FDA approval for their PillStation, a revolutionary new Medication Adherence Telehealth System designed to reduce re-hospitalization and doctor visits. Developed with a focus to significantly lower complications and improve health by assuring medication compliance with significant cost savings for the healthcare industry, PillStation is designed to combat CHF and other chronic disease related hospital readmissions. Using patent pending technology, PillStation transmits images of patient’s medications from within their PillStation and works with patients on complicated medication regimens to be sure that patients can self-administer the correct medications at the correct time. The companies new system will be showcased this month at the 11th annual HIMSS conference and exhibition (Booth #4005) in Orlando, Florida from February 20 – 24.

The only telehealth system developed which aggregates a list of patient’s prescription drugs, and provides direct visualization of medication, PillStation’s unique technology platform provides clear images of the medications being loaded and takes up-to-date images of the prescriptions after each use. The images, along with other critical data, are sent to the SentiCare Advisor Center for medications management and monitoring 24 hours a day, seven days a week. Additionally, PillStation provides secure web access for real-time information regarding adherence and integrates with EMR/PHR services.

Studies show that approximately 29 – 47% of elderly patients with CHF are readmitted within three to six months of discharge and that approximately 125,000 Americans die each year due to Medication Non-Adherence, while almost 60% of the prescription Medication Non-Adherence problems could be prevented. Using proprietary hardware, software and call center protocols, SentiCare’s state-of-the-art technology is uniquely developed to address healthcare issues related to Medication Non-Adherence.  These issues, which result in rising cost and risk, especially with patients managing CHF and other chronic conditions, include:

• Forgetting to take medication

• Discontinuing or taking medication prematurely

• Not filling or refilling a prescription

SentiCare Receives FDA Approval Release / Pg. 2

• Taking incorrect medication

• Taking incorrect dosage

• Taking the right medication at the wrong time

• Double dosing to make up for a skipped dose

• Combining medication with inappropriate food or beverage

PillStation trials have achieved adherence levels on multiple medications of approximately 98%, compared to an expected baseline in equivalent patients of 40%.  Economic modeling shows that cardiovascular conditions such as CHF are especially likely to benefit from PillStation in terms of both quality and dramatically lowered cost. SentiCare’s new telehealth system offers substantial cost savings, which could result in saving millions of dollars per year, for hospitals, Accountable Care Organizations (ACOs) and physician groups.

“With recent healthcare reform and the advent of new models for healthcare delivery, including the establishment of ACOs, Medication Adherence and remote patient monitoring are emerging as some of the most important areas of healthcare innovation,” stated company co-founder, Yogendra Jain.  “IT models like PillStation, support new health care delivery systems like ACOs, where the exchange of data is critical,” he added.

Check out our website for an online product demo video or for more information or a real time demo on SentiCare’s new PillStation, stop by Booth #4005 at the HIMMS conference in Orlando from February 20 – 24, or call 603-929-6664 to schedule an interview.  HIMMS is a cause-based, not-for-profit organization exclusively focused on providing global leadership for the optimal use of information technology (IT) and management systems for the betterment of healthcare.

About SentiCare

Founded in 2008 and located in Southborough MA, SentiCare has developed a unique, solution to the serious and costly problem of Medication Non-Adherence.  Using proprietary hardware, software and call center protocols, SentiCare works with patients on complicated medication regimens to be sure that patients take the correct medications at the correct time.  Proper adherence leads to improved health outcomes, reduced hospitalization, reduced re-admission within 30-90 days after discharge, and significant cost savings for Healthcare and Senior Housing Providers.  SentiCare’s approach is unique and targets eight identified attributes that are the root cause of non-adherence. The PillStation product and service are in full production.  www.senticare.com

   

Categories